These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29876834)

  • 1. Predicting Adverse Drug Effects from Literature- and Database-Mined Assertions.
    La MK; Sedykh A; Fourches D; Muratov E; Tropsha A
    Drug Saf; 2018 Nov; 41(11):1059-1072. PubMed ID: 29876834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug events: database construction and in silico prediction.
    Cheng F; Li W; Wang X; Zhou Y; Wu Z; Shen J; Tang Y
    J Chem Inf Model; 2013 Apr; 53(4):744-52. PubMed ID: 23521697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams.
    Eshleman R; Singh R
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):335. PubMed ID: 27766937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data mining methodology for response to hypertension symptomology-application to COVID-19-related pharmacovigilance.
    Xu X; Kawakami J; Millagaha Gedara NI; Riviere JE; Meyer E; Wyckoff GJ; Jaberi-Douraki M
    Elife; 2021 Nov; 10():. PubMed ID: 34812146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A data-driven method to detect adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    J Biomed Inform; 2018 Sep; 85():10-20. PubMed ID: 30016721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining multi-item drug adverse effect associations in spontaneous reporting systems.
    Harpaz R; Chase HS; Friedman C
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S7. PubMed ID: 21044365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records.
    Banda JM; Callahan A; Winnenburg R; Strasberg HR; Cami A; Reis BY; Vilar S; Hripcsak G; Dumontier M; Shah NH
    Drug Saf; 2016 Jan; 39(1):45-57. PubMed ID: 26446143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for systematic discovery of adverse drug events from clinical notes.
    Wang G; Jung K; Winnenburg R; Shah NH
    J Am Med Inform Assoc; 2015 Nov; 22(6):1196-204. PubMed ID: 26232442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in text-mined possible adverse drug events associated with drugs for psychosis.
    Sørup FKH; Eriksson R; Westergaard D; Hallas J; Brunak S; Ejdrup Andersen S
    J Psychopharmacol; 2020 May; 34(5):532-539. PubMed ID: 32048538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel data-mining methodologies for adverse drug event discovery and analysis.
    Harpaz R; DuMouchel W; Shah NH; Madigan D; Ryan P; Friedman C
    Clin Pharmacol Ther; 2012 Jun; 91(6):1010-21. PubMed ID: 22549283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
    Winnenburg R; Sorbello A; Ripple A; Harpaz R; Tonning J; Szarfman A; Francis H; Bodenreider O
    J Biomed Inform; 2015 Oct; 57():425-35. PubMed ID: 26342964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
    Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
    BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving postapproval drug safety surveillance: getting better information sooner.
    Hennessy S; Strom BL
    Annu Rev Pharmacol Toxicol; 2015; 55():75-87. PubMed ID: 25292435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.
    Tenhunen ML; Smithers B; Tucker B
    Consult Pharm; 2016; 31(8):436-9. PubMed ID: 27535078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction of relations between genes and diseases from text and large-scale data analysis: implications for translational research.
    Bravo À; Piñero J; Queralt-Rosinach N; Rautschka M; Furlong LI
    BMC Bioinformatics; 2015 Feb; 16():55. PubMed ID: 25886734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients.
    Díaz Hernández SH; Cruz-Gonzalez I
    Consult Pharm; 2018 Aug; 33(8):454-466. PubMed ID: 30068439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.